…
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
CareRx Corp (CRRX.TO) provides pharmacy services for seniors and long-term care in Canada, including institutional pharmacy management, medication dispensing, compliance packaging and digital medication-support tools. Long-term growth drivers include an aging population, rising demand for institutional and home-based medication management and contract or acquisition-driven scale, which may benefit recurring revenue and operational efficiency.
Primary risks are dependence on government funding and reimbursement policies, execution risk from acquisitions, competitive pressure from larger pharmacy chains and operational challenges such as workforce constraints and supply disruptions that investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 3.35M | -4.47M | -9.60M | -35.90M | -23.73M |
| Net income | 26.13M | -4.50M | -5.41M | -34.35M | -22.73M |
| Selling general administrative | 34.23M | 32.75M | 30.66M | 34.43M | 25.13M |
| Selling and marketing expenses | - | - | 46.83M | - | - |
| Gross profit | 92.63M | 108.06M | 84.72M | 109.93M | 75.28M |
| Reconciled depreciation | 18.33M | 19.19M | 19.98M | 20.07M | 15.39M |
| Ebit | 11.88M | 4.71M | 4.67M | 7.91M | 4.71M |
| Ebitda | 30.22M | 23.90M | 24.65M | 27.98M | 20.11M |
| Depreciation and amortization | 18.33M | 19.19M | 19.98M | 20.07M | 15.39M |
| Operating income | 11.88M | 4.53M | 4.67M | 7.91M | 4.71M |
| Other operating expenses | 358.36M | 362.19M | 366.08M | 374.09M | 257.82M |
| Interest expense | 6.84M | 9.18M | 14.27M | 15.22M | 14.49M |
| Tax provision | -22.77M | 0.03M | -4.19M | -1.54M | -1.00M |
| Interest income | 0.16M | 9.12M | 1.26M | 0.28M | 16.83M |
| Net interest income | -6.68M | -9.12M | -13.01M | -14.94M | -14.59M |
| Extraordinary items | - | - | - | - | 0.00M |
| Income tax expense | -22.77M | 0.03M | -4.19M | -1.54M | -1.00M |
| Total revenue | 370.24M | 366.71M | 370.75M | 381.73M | 262.63M |
| Total operating expenses | 80.75M | 103.53M | 100.03M | 102.30M | 70.47M |
| Cost of revenue | 277.61M | 258.65M | 286.02M | 271.79M | 187.35M |
| Total other income expense net | -8.53M | -8.99M | -14.27M | -43.81M | -28.45M |
| Net income from continuing ops | 26.13M | -4.50M | -5.41M | -34.35M | -22.73M |
| Net income applicable to common shares | - | -4.50M | -5.41M | -34.35M | -22.73M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 253.02M | 223.54M | 231.89M | 264.54M | 282.82M |
| Intangible assets | 28.89M | 34.30M | 44.33M | 52.95M | 54.57M |
| Other current assets | 2.17M | 1.95M | 1.96M | 2.56M | 3.52M |
| Total liab | 143.51M | 139.31M | 150.37M | 200.08M | 200.53M |
| Total stockholder equity | 109.50M | 84.23M | 81.53M | 64.46M | 82.29M |
| Other current liab | 20.51M | 1.19M | 20.97M | 23.40M | 18.50M |
| Common stock | 332.49M | - | 323.30M | 299.78M | 283.46M |
| Capital stock | 332.49M | 331.11M | 323.30M | 299.78M | 283.46M |
| Retained earnings | -263.58M | -287.19M | -282.69M | -277.28M | -242.93M |
| Other liab | - | - | - | 10.97M | 17.39M |
| Good will | 70.01M | 70.01M | 70.01M | 70.01M | 92.11M |
| Cash | 14.40M | 9.08M | 7.71M | 28.37M | 35.62M |
| Cash and equivalents | - | - | - | 28.37M | 35.62M |
| Total current liabilities | 63.03M | 62.80M | 62.45M | 63.89M | 52.97M |
| Current deferred revenue | 0.76M | - | - | - | - |
| Net debt | 63.53M | 36.20M | 89.81M | 106.85M | 89.95M |
| Short term debt | 7.87M | - | 12.37M | 10.01M | 1.27M |
| Short long term debt | 5.10M | 5.33M | 9.92M | 7.41M | 0.73M |
| Short long term debt total | 77.92M | - | 97.52M | 135.22M | 125.57M |
| Other stockholder equity | 40.59M | - | 33.62M | 41.96M | 41.76M |
| Property plant equipment | - | - | - | 52.39M | 38.17M |
| Total current assets | 67.02M | 62.34M | 65.41M | 89.18M | 95.25M |
| Long term investments | - | - | - | 0.00M | 2.71M |
| Net tangible assets | - | - | - | -58.51M | -64.40M |
| Net receivables | 32.90M | 32.43M | 36.09M | 37.26M | 38.11M |
| Long term debt | 35.96M | 39.96M | 57.15M | 99.37M | 111.97M |
| Inventory | 17.55M | 17.67M | 19.66M | 20.30M | 17.99M |
| Accounts payable | 33.89M | 31.83M | 29.11M | 30.48M | 33.21M |
| Accumulated other comprehensive income | - | - | 7.30M | - | - |
| Non current assets total | 186.00M | 161.20M | 166.48M | 175.36M | 187.57M |
| Capital lease obligations | 36.86M | 37.34M | 30.79M | 28.44M | 18.73M |
| Long term debt total | - | - | - | 125.22M | 130.16M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -7.92M | -12.31M | -16.60M | -93.18M |
| Change to liabilities | - | - | - | 0.82M | 15.00M |
| Total cashflows from investing activities | -8.26M | -7.92M | -12.31M | -16.60M | -93.18M |
| Net borrowings | -10.96M | -21.58M | -39.82M | -5.29M | 30.35M |
| Total cash from financing activities | -14.44M | -28.02M | -36.40M | -12.99M | 101.91M |
| Change to operating activities | - | - | - | 0.31M | -5.17M |
| Net income | 26.13M | -4.50M | -5.41M | -34.35M | -22.73M |
| Change in cash | 4.83M | 2.06M | -21.34M | -7.25M | 16.00M |
| Begin period cash flow | 9.56M | 7.03M | 29.05M | 35.62M | 19.62M |
| End period cash flow | 14.40M | 9.08M | 7.71M | 28.37M | 35.62M |
| Total cash from operating activities | 27.54M | 37.99M | 27.38M | 22.33M | 7.27M |
| Issuance of capital stock | 0.01M | 0.00M | 14.68M | 1.01M | 80.86M |
| Depreciation | 18.33M | 19.19M | 19.98M | 20.07M | 15.39M |
| Other cashflows from investing activities | - | -2.53M | -3.93M | -2.98M | -86.06M |
| Dividends paid | 1.26M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | -0.13M | 1.55M | 0.65M | -2.00M | -2.83M |
| Change to account receivables | 0.25M | 3.82M | 1.47M | 1.51M | -10.72M |
| Sale purchase of stock | -2.24M | -0.80M | -0.06M | 1.01M | 80.86M |
| Other cashflows from financing activities | -7.90M | -5.63M | -11.20M | -8.71M | 51.69M |
| Change to netincome | - | - | - | 35.98M | 18.33M |
| Capital expenditures | 5.58M | 8.11M | 8.70M | 13.61M | 7.12M |
| Change in working capital | -0.99M | 8.98M | 2.12M | 0.64M | -3.73M |
| Stock based compensation | 2.71M | 3.65M | 1.47M | 4.57M | 2.67M |
| Other non cash items | -15.94M | 10.64M | 13.40M | 32.96M | 16.67M |
| Free cash flow | 21.95M | 29.88M | 18.68M | 8.72M | 0.15M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRRX CareRx Corp |
0.05 1.49% |
3.41 | 9.12 | 21.37 | 0.63 | 2.14 | 0.81 | 10.47 |
| EXE Extendicare Inc |
1.47 5.50% |
28.22 | 25.21 | 23.92 | 1.59 | 7.26 | 1.62 | 14.43 |
| SIA Sienna Senior Living Inc |
0.52 2.65% |
20.13 | 45.94 | 38.17 | 2.23 | 3.17 | 3.57 | 21.90 |
| WELL WELL Health Technologies Corp |
-0.02 0.48% |
4.15 | - | 13.87 | 0.80 | 1.23 | 1.09 | 9.83 |
| DR Medical Facilities Corporation |
0.16 1.08% |
15.01 | 15.57 | 12.94 | 1.18 | 2.87 | 0.92 | 3.64 |
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. David Murphy | Pres, CEO & Director | NA |
| Mr. Andrew Mok | Chief Financial Officer | NA |
| Mr. Puneet Khanna | Chief Operating Officer | NA |
| Mr. Paul Rakowski | Sr. VP of Corp. Devel., Gen. Counsel, Chief Privacy Officer and Corp. Sec. | NA |
| Ms. Adrianne Sullivan Campeau | Chief People & Culture Officer | NA |
| Mr. Ryan Stempfle | VP & GM of Western Canada for the Specialty Pharmacy Division | NA |
| Mr. Puneet Khanna | CEO, President & Director | NA |
| Mr. Paul Rakowski | Senior VP of Corporate Development, General Counsel, Chief Privacy Officer & Corporate Secretary | NA |
| Mr. Travis Featherstone | Senior VP of Western Operations & System Integration | NA |
| Ms. Suzanne Brand | Chief Financial Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.